RSVpreF is named as a drug or biological intervention in 4 clinical trials in our USA, China and India trial registers, 2 of which are recruiting. The lead sponsor is Pfizer. Registered phase: Phase 3. Conditions studied include Lower Respiratory Tract Illness; RSV Infection; Adult.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06866405 | A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose (ClinicalTrials.gov ↗) RSV Infection |
Phase 3 | Recruiting |
| NCT07653100 | A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF (ClinicalTrials.gov ↗) Respiratory Syncytial Virus (RSV) |
Phase 3 | Recruiting |
| NCT07819097 | A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults (ClinicalTrials.gov ↗) Adult, Healthy Participants |
Phase 3 | Not yet open |
| NCT05035212 | Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. (ClinicalTrials.gov ↗) Lower Respiratory Tract Illness |
Phase 3 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Lower Respiratory Tract Illness | 1 |
| RSV Infection | 1 |
| Adult | 1 |
| Healthy Participants | 1 |
| Respiratory Syncytial Virus (RSV) | 1 |
| Lead sponsor | Trials |
|---|---|
| Pfizer | 4 |
| Register | RSVpreF trials |
|---|---|
| Clinical trials in USA | 3 |
| Clinical trials in China | 1 |
| Clinical trials in India | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how RSVpreF works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists RSVpreF (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.